LDL cholesterol-to-apo B ratio is a potential indicator of LDL particle size and plasma atherogenicity in type 2 diabetes (T2DM) as well as a potential indicator of increased cardiovascular risk in these patients. Here, APOB is linked to type 2 diabetes mellitus.